These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28951089)

  • 21. Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy.
    Evans JR; Zhao S; Daignault S; Sanda MG; Michalski J; Sandler HM; Kuban DA; Ciezki J; Kaplan ID; Zietman AL; Hembroff L; Feng FY; Suy S; Skolarus TA; McLaughlin PW; Wei JT; Dunn RL; Finkelstein SE; Mantz CA; Collins SP; Hamstra DA;
    Radiother Oncol; 2015 Aug; 116(2):179-84. PubMed ID: 26276528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
    Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016).
    Staffurth JN; Haviland JS; Wilkins A; Syndikus I; Khoo V; Bloomfield D; Parker C; Logue J; Scrase C; Birtle A; Malik Z; Panades M; Eswar C; Graham J; Russell M; Ferguson C; O'Sullivan JM; Cruickshank CA; Dearnaley D; Hall E;
    Eur Urol Oncol; 2021 Dec; 4(6):980-992. PubMed ID: 34489210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial.
    Bruner DW; Pugh SL; Lee WR; Hall WA; Dignam JJ; Low D; Swanson GP; Shah AB; Malone S; Michalski JM; Dayes IS; Seaward SA; Nguyen PL; Pisansky TM; Chen Y; Sandler HM; Movsas B
    JAMA Oncol; 2019 May; 5(5):664-670. PubMed ID: 30763425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.
    Movsas B; Hu C; Sloan J; Bradley J; Komaki R; Masters G; Kavadi V; Narayan S; Michalski J; Johnson DW; Koprowski C; Curran WJ; Garces YI; Gaur R; Wynn RB; Schallenkamp J; Gelblum DY; MacRae RM; Paulus R; Choy H
    JAMA Oncol; 2016 Mar; 2(3):359-67. PubMed ID: 26606200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensity-modulated radiotherapy of prostate cancer with simultaneous integrated boost after molecular imaging with 18F-choline-PET/CT : Clinical results and quality of life.
    Schlenter M; Berneking V; Krenkel B; Mottaghy FM; Vögeli TA; Eble MJ; Pinkawa M
    Strahlenther Onkol; 2018 Jul; 194(7):638-645. PubMed ID: 29511777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stamp test delivers message on erectile dysfunction after high-dose intensity-modulated radiotherapy for prostate cancer.
    Keller LM; Buyyounouski MK; Sopka D; Ruth K; Klayton T; Pollack A; Watkins-Bruner D; Greenberg R; Price R; Horwitz EM
    Urology; 2012 Aug; 80(2):337-42. PubMed ID: 22749428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate Cancer.
    Zhang E; Ruth KJ; Buyyounouski MK; Price RA; Uzzo RG; Sobczak ML; Pollack A; Wong JK; Chen DYT; Hallman MA; Greenberg RE; Watkins-Bruner D; Al-Saleem T; Horwitz EM
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1074-1084. PubMed ID: 36566906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of Life After Radiation Therapy for Prostate Cancer With a Hydrogel Spacer: 5-Year Results.
    Pinkawa M; Berneking V; Schlenter M; Krenkel B; Eble MJ
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):374-377. PubMed ID: 28871986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of hormonal therapy on sexual quality of life in men receiving intensity modulated radiation therapy for prostate cancer.
    Son CH; Chennupati SK; Kunnavakkam R; Liauw SL
    Pract Radiat Oncol; 2015; 5(3):e223-e228. PubMed ID: 25491179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrogel injection reduces rectal toxicity after radiotherapy for localized prostate cancer.
    Pinkawa M; Berneking V; König L; Frank D; Bretgeld M; Eble MJ
    Strahlenther Onkol; 2017 Jan; 193(1):22-28. PubMed ID: 27632342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer.
    Hoppe BS; Michalski JM; Mendenhall NP; Morris CG; Henderson RH; Nichols RC; Mendenhall WM; Williams CR; Regan MM; Chipman JJ; Crociani CM; Sandler HM; Sanda MG; Hamstra DA
    Cancer; 2014 Apr; 120(7):1076-82. PubMed ID: 24382757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification.
    Lips IM; van Gils CH; van der Heide UA; Kruger AE; van Vulpen M
    BJU Int; 2009 Mar; 103(6):762-7. PubMed ID: 18990145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding.
    Lee JY; Daignault-Newton S; Heath G; Scarlett S; Sanda MG; Chang P; Regan MM; Michalski JM; Sandler HM; Feng FY; Kuban DA; Zietman AL; Ciezki JP; Kaplan ID; Crociani C; McLaughlin WP; Mantz CA; Finkelstein SE; Suy S; Collins SP; Garin O; Ferrer M; Hamstra DA; Spratt DE
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):770-777. PubMed ID: 27663760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger.
    Hoppe BS; Nichols RC; Henderson RH; Morris CG; Williams CR; Costa J; Marcus RB; Mendenhall WM; Li Z; Mendenhall NP
    Cancer; 2012 Sep; 118(18):4619-26. PubMed ID: 22253020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience.
    Hamstra DA; Conlon AS; Daignault S; Dunn RL; Sandler HM; Hembroff AL; Zietman AL; Kaplan I; Ciezki J; Kuban DA; Wei JT; Sanda MG; Michalski JM;
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):546-53. PubMed ID: 23561651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
    Rodda S; Morris WJ; Hamm J; Duncan G
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):581-589. PubMed ID: 28581398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: assessing the impact of margin reduction study.
    Sandler HM; Liu PY; Dunn RL; Khan DC; Tropper SE; Sanda MG; Mantz CA
    Urology; 2010 May; 75(5):1004-8. PubMed ID: 20153881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.